Cargando…
Tetraspanin CD151 as an emerging potential poor prognostic factor across solid tumors: a systematic review and meta-analysis
Tetraspanin CD151, also known as PETA-3 or SFA-1, has been reported to predict prognosis in various solid tumors. Yet, the results of these studies remained inconclusive. Here, we performed this meta-analysis of relevant studies published on the topic to quantitatively evaluate the clinicopathologic...
Autores principales: | Zeng, Ping, Wang, Yin-Hua, Si, Meng, Gu, Jin-Hua, Li, Ping, Lu, Pei-Hua, Chen, Min-Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354932/ https://www.ncbi.nlm.nih.gov/pubmed/27888619 http://dx.doi.org/10.18632/oncotarget.13532 |
Ejemplares similares
-
Tetraspanin CD151 is a novel prognostic marker in poor outcome endometrial cancer
por: Voss, M A, et al.
Publicado: (2011) -
The Tetraspanin CD151 in Papillomavirus Infection
por: Scheffer, Konstanze D., et al.
Publicado: (2014) -
Kidney failure in mice lacking the tetraspanin CD151
por: Sachs, Norman, et al.
Publicado: (2006) -
Profiling of the Tetraspanin CD151 Web and Conspiracy of CD151/Integrin β1 Complex in the Progression of Hepatocellular Carcinoma
por: Devbhandari, Ranjan Prasad, et al.
Publicado: (2011) -
The tetraspanin CD151-ARSA mutant inhibits angiogenesis via the YRSL sequence
por: PENG, DAN, et al.
Publicado: (2013)